Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Farinati

Showing results (161-170 of 253) with videos related to

Pageof 26
Sort By:
Plos One|September 14, 2011
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapiesAlessandro Vitale, Filippo Navaglia, Rafael Ramírez Morales, et al.
Seminars in Oncology|July 16, 2014
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parametersBrian I Carr, Petr Pancoska, Edoardo G Giannini, et al.
Seminars in Oncology|May 3, 2014
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotypeBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
The American Journal of Gastroenterology|August 17, 2004
Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survivalFranco Trevisani, Maria C Cantarini, Antonello M M Labate, et al.
Helicobacter|June 21, 2018
The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practiceRocco Maurizio Zagari, Alessandra Romiti, Enzo Ierardi, et al.
The American Journal of Gastroenterology|March 18, 2006
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Fabio Farinati, Dario Marino, Massimo De Giorgio, et al.
Pathology, Research and Practice|May 1, 2021
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimensMatteo Fassan, Claudia Mescoli, Marta Sbaraglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2014
Changes in microRNA expression during disease progression in patients with chronic viral hepatitisAlessandro Sinigaglia, Enrico Lavezzo, Marta Trevisan, et al.
Cancers|April 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept StudyElisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, et al.
Hepatology (Baltimore, Md.)|April 27, 2012
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosisEdoardo G Giannini, Simona Marenco, Giacomo Borgonovo, et al.
Pageof 26

Showing results (161-170 of 253) with videos related to

Sort By:
Pageof 26
Plos One|September 14, 2011
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapiesAlessandro Vitale, Filippo Navaglia, Rafael Ramírez Morales, et al.
Seminars in Oncology|July 16, 2014
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parametersBrian I Carr, Petr Pancoska, Edoardo G Giannini, et al.
Seminars in Oncology|May 3, 2014
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotypeBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
The American Journal of Gastroenterology|August 17, 2004
Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survivalFranco Trevisani, Maria C Cantarini, Antonello M M Labate, et al.
Helicobacter|June 21, 2018
The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practiceRocco Maurizio Zagari, Alessandra Romiti, Enzo Ierardi, et al.
The American Journal of Gastroenterology|March 18, 2006
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Fabio Farinati, Dario Marino, Massimo De Giorgio, et al.
Pathology, Research and Practice|May 1, 2021
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimensMatteo Fassan, Claudia Mescoli, Marta Sbaraglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2014
Changes in microRNA expression during disease progression in patients with chronic viral hepatitisAlessandro Sinigaglia, Enrico Lavezzo, Marta Trevisan, et al.
Cancers|April 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept StudyElisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, et al.
Hepatology (Baltimore, Md.)|April 27, 2012
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosisEdoardo G Giannini, Simona Marenco, Giacomo Borgonovo, et al.
Pageof 26